Quantitative microvessel density: A staging and prognostic marker for human prostatic carcinoma

Cancer

Volumn 78, Issue 2, 1996, Pages 345-349

  Drawer, Michael K ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

angiogenesis; neovascularity; prognosis; prostate carcinoma; staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANGIOGENESIS; BASEMENT MEMBRANE; CANCER STAGING; CARCINOMA IN SITU; CONFERENCE PAPER; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; TRANSURETHRAL RESECTION; TUMOR GROWTH;

BIOPSY, NEEDLE; BLOOD VESSELS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FORECASTING; HUMANS; MALE; MICROCIRCULATION; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0030058408     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960715)78:2<345::AID-CNCR25>3.0.CO;2-V     Document Type: Conference Paper

References (25)

1. Wingo PA, Tong T, Bolden S. Cancer Statistics, 1995. CA Cancer J Clin 1995; 45:8-30.
2. Scardino PT, Weaver R, Hudson MA. Early detection of prostate cancer. Human Pathol 1992; 23(3):211-22.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182.
4. Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 1966; 164:491.
5. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-4.
6. Leibovich SJ, Polverinin PJ, Shepard MH, Wiseman DM, Shively V, Nureddin N. Macrophage induced angiogenesis is mediated by tumor necrosis Factor A. Nature 1987; 329:630-2.
7. Folkman J, Klagsburm M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein - basic fibroplast growth factor - is stored within the basement membrane. Am J Pathol 1988; 130:393-400.
8. Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak AM, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1988; 948:305-26.
9. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, et al. Tumor vascular permeability factor stimulates endothilial cell growth and angiogenesis. J Clin Invest 1989; 84:1470-8.
10. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
11. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84:1875-87.
12. Chodak GW, Haudenschild C, Gittes RF, Folkman J. Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the bladder. Ann Surg 1980; 192:762.
13. Sillman F, Boyce J, Frutcher R. The significance of atypical vessels and neovascularization in cervical neoplastic. Am J Obstet Gynecol 1981; 139:154.
14. Srivastava A, Laidler P, Davies R, Horgan K, Hughes L. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988; 133:419.
15. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994; 73(3):678-87.
16. Deering RE, Bigler SA, Brown M, Brawer MK. Microvascularity in BPH. Prostate 1995; 26(3):111-5.
17. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75(10):2545-51.
18. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24(2):220-6.
19. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143:401-9.
20. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992; 168:257-62.
21. Brawer MK, Bostwick DM, Peehl DM, Stamey TA, Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985; 45(8):3663-7.
22. Deering RE, Bigler SA, Brown M, Brawer MK. Microvascularity in BPH. J Urol 1994; 151(Suppl):314A.
23. Bostwick DG, Wheeler TM, Miles MJ, Scardino PT, Humphrey PA, Hudson MA, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology In press.
24. Brawer MK, Jonsson E, Gibbons RP, Deering RE, Bigler SA, Preston SD. Extent of prostate neovascularity predicts progression in patients with pathologic stage C adenocarcinoma treated with radical prostatectomy. J Urol 1994; 151(Suppl 246):289A.
25. Hall MC, Troncoso P, Pollack A, Zhau HYE, Zagars GK, Chung LWK, von Eschenbach AC. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 1994; 44(6):869-75.